Doug provides expertise in biotechnology, biopharmaceuticals, specialty medical products, and healthcare innovation. He has served on more than 20 public and private boards, typically sitting on three to five boards at a given time. Currently, Doug serves on the board for Arrowhead Pharmaceuticals, Inc. and Vivaldi Biosciences Inc.
An active and engaged board member, Doug works hand-in-hand with the executives and investors in each setting to develop leaders who execute effective growth strategies, attract capital and create value. He makes their success his priority, offering expert guidance on governance, strategy, corporate and business development and R&D.
Doug also shares informed biopharmaceutical industry perspectives and readily acts as a trusted intermediary making introductions to a wide range of appropriate and qualified financing sources. He leverages a vast professional network comprised of business leaders, venture capitalists, private equity investors, and world-class researchers and academicians.